Renal dysfunction in AQP4 NMOSD and MS; a potential predictor of relapse and prognosis

CONCLUSIONS: The eGFR of patients with AQP4-IgG-seropositive NMOSD emerges as a potential diagnostic biomarker for this condition, indicating its significance in predicting both relapse risk and clinical prognosis.PMID:38141747 | DOI:10.1016/j.clim.2023.109875

Source: Clinical Immunology - December 23, 2023 Category: Allergy & Immunology Authors: Yongkang Chen Yilin Wang Ruoqi Jin Zheng Lv Yu Fu Junfang Teng Xuejing Wang Source Type: research